Raffaella Greco, Italy
Raffaella Greco
Senior Physician in the Hematology and Blood/Marrow Transplant (BMT) Unit of the IRCCS San Raffaele Hospital in Milano, Italy. Hematologist involved in hematopoietic stem cell transplantation (HSCT) and cellular therapies in all spectrum of haematological cancers and non-malignant indications, including autoimmune diseases.Her expertise in this field encompasses allogeneic and autologous stem cell transplantation (malignant and non-malignant diseases), cellular therapies (i.e. CART cells, Treg-based cell therapies), immune reconstitution, biomarkers, transplant complications (i.e graft versus host disease, infections). Her career has been focused on several clinical research projects on HSCT and cellular therapies. She has (co-)authored many research articles in peer reviewed journal as well as reviews, book chapters and best-practice guidelines in the field.She has been significantly involved with the European Group for Blood and Marrow Transplantation (EBMT), as Autoimmune Diseases Working Party (ADWP) Chair (2020-24), EBMT Scientific Council Representative with the Education Portfolio (2022-24), co-chair of the EBMT Harmonization Committee (2022-24), EBMT secretary (2024-ongoing), active member of the ADWP and Cellular Therapy & Immunobiology Working Party (CTIWP).
Dror Mevorach, Israel
Dror Mevorach
Dr. Dror Mevorach is a Full Professor and Director of the Rheumatology-Immunology-Allergology Institute at Hadassah Medical Center, affiliated with the Hebrew University in Jerusalem, Israel. He obtained his medical degree cum laude from the Technion Institute, Haifa, Israel, in 1988. His expertise spans autoimmune and autoinflammatory diseases, particularly through the study of innate immunity and apoptotic cell clearance. Throughout his career, Dr. Mevorach has held various prestigious positions, including Senior Physician and Chairman of Medicine at Hadassah University Hospital. He has led innovative research in autoimmune diseases, contributing to breakthroughs in the understanding and treatment of conditions like lupus and graft-versus-host disease. Dr. Mevorach’s research has also resulted in therapeutic applications, such as the development of advanced cellular therapies with apoptotic cells, now commercialized by Enlivex Therapeutics. He has published extensively in renowned journals and has received numerous awards for his contributions to medicine, including recognition from the Hebrew University Medical Faculty and the Arthritis Foundation.
Arnon Nagler, Israel
Arnon Nagler
Chaim Sheba Medical Center, Israel
- Director of the Division of Hematology, Chaim Sheba Medical Center, Israel
- Director of Bone Marrow transplantation and Cord Blood Bank, Chaim Sheba Medical Center, Israel
- Professor of Medicine at the Tel Aviv University, Tel Aviv, Israel
- One of the pioneers of the non-myeloablative and reduced intensity/toxicity allogeneic transplantations for both malignant and non-malignant disorders (Blood 1998)
- Established the first public cord blood bank and performed the first cord blood transplanataion in Israel
- Leader of the Alternative donor subcommittee of the ALWP of the EBMT from 2008-2010
- Leader of the RIC subcommittee of the ALWP of the EBMT – since 2010
- Serves on the Editorial Board of several BMT and Hematology Journals and is a Section Editor for Leukemia
- Chair of the Acute Leukemia Working Party (ALWP) of the EBMT
Dr Nagler received his medical training at the Hebrew University-Hadassah Medical School, Jerusalem, Israel; he then carried out a Postdoctoral research fellowship in hematology and bone marrow transplantation at “Stanford University Hospital” Palo Alto, CA, in the USA, from 1986 to 1990.
Dr Nagler serves on the Board of Directors of Netcord organization of cord blood banks and was the Netcord Threasurer from 2010-2013.
Dr Nagler has received several awards including the best scientific abstract award of the ASBMT/CIBMR Tandem meeting (2004) and the best clinical abstract award of the NMDP Council Meeting (2004). In addition, Dr Nagler is a popular speaker and has made numerous, invited, international presentations and many Oral presentations on almost annual basis in all international transplantation and hematology meetings – ASH,ASBMT/CIBMTR, EBMT, EHA, Exp Hematology (including a presentation at the presidential symposium) and invited presentation at the Gordon conference (Boston USA).
William Robinson, USA
William Robinson
Dr. Robinson leads a translational immunology laboratory focused on elucidating the role of Epstein–Barr virus (EBV) and other microbial drivers in the pathogenesis of autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS). His laboratory pioneered the development of high-density protein arrays and advanced high-throughput sequencing technologies to directly identify EBV-infected B cells, define antibody specificities, and dissect mechanisms of immune dysregulation. Using these platforms, his group demonstrated that EBV directly infects and transcriptionally reprograms autoreactive B cells into pathogenic antigen-presenting cells that initiate and amplify autoreactive T- and B-cell responses driving the pathogenesis of SLE and MS.
Dr. Robinson co-founded the Stanford Human Immune Monitoring Center and has served in numerous national leadership roles in immunology. He currently serves as Treasurer and a member of the Board of Directors of the Federation of Clinical Immunology Societies and sits on the editorial boards of multiple journals. An inventor on 23 patent applications, technologies developed in his Stanford and VA laboratories have been licensed to nine biotechnology companies. He was elected to the American Society for Clinical Investigation (ASCI), the Henry Kunkel Society, and the Association of American Physicians (AAP). Dr. Robinson received his MD and PhD degrees from Stanford University and completed his residency training in internal medicine at the University of California, San Francisco.
Henrik Schulze-Koops, Germany
Henrik Schulze-Koops
Education and Professional Experience
2023 Board Exam Immunology, Bayerische Landesärztekammer, Munich
since 11/2015 Schwerpunktprofessor for Rheumatology und Clinical Immunology, LMU Klinikum, University of Munich
since 11/2006 Appointed as Full Professor of Internal Medicine, Rheumatology and Clinical Immunology, University of Munich
Chair of the Division of Rheumatology and Clinical Immunology, University of Munich
09/2006 Appointed as Associated Professor of Clinical Immunology, University of Erlangen
2003 – 2006 Senior Physician, Department of Internal Medicine III, University of Erlangen
2003 Board Exam Rheumatology, Bayerische Landesärztekammer, Munich
Certified as Immunologist (German Society for Immunology)
2002 Board Exam Internal Medicine, Bayerische Landesärztekammer, Munich
1997 – 2003 Chief Resident, Department of Internal Medicine III, University of Erlangen
- Habilitation [T cells in the pathogenesis of human autoimmune diseases]
1999 – 2006 Head of the Clinical Research Group „T cells in the pathogenesis of autoimmune diseases“, University of Erlangen
1995 – 1997 Postdoctoral Fellow and Research Associate; Harold C. Simmons Arthritis Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA
1990 – 1993 Postdoctoral Fellow; Clinical Research Groups for Rheumatology/Immunology of the Max Planck Society at the Institute for Clinical Immunology of the University of Erlangen-Nuremberg
01/07/1990 Medical licensure
1989 – 1990 Resident in Internal Medicine; University Hospital Eppendorf, Hamburg
1982 – 1988 Medical School, University of Hamburg, Hamburg
Honors and Awards
2025 – Liaison-Officer of ACR and EULAR for the development of classification criteria for musculoskeletal side effects of checkpoint inhibitor therapies
2025 Coordinator for the EULAR points to consider for the management of patients with musculoskeletal side effects of checkpoint inhibitor therapies
2024 – Member of the Advisory Board of the German Society of Internal Medicine
2024 Coordinator of the S3 guideline Management of Early Rheumatoid Arthritis of the German Society of Rheumatology
2023 – Member of the Advisory Board of the German Society of Rheumatology and Clinical Immunology
2022 Scientific Chair of EULAR
2022 – Member of the expert advisory board and specialist examiner in immunology of the Bavarian Medical Association
2024, 2023, 2021, 2020, 2018, 2017, 2015, 2014
Awards for excellent teaching at the University of Munich
2021 Abstract Chair of EULAR
2021 – 2024 Member of the Advisory Board of the German Society of Internal Medicine
2020 President of the 48th Annual Meeting of the German Society of Rheumatology
2019 – 2020 President of the German Society of Rheumatology
2018 – 2021 Member of the EULAR Scientific Core Programme Committee
2016 Nominated Chief of Rheumatology at the University of Hamburg (W3, rejected)
2016 Elected as member of the Permanent Commission for Clinical Research of the Senat of the Deutsche Forschungsgemeinschaft
2016 – 2019 Chair of the Fachkollegium Medizin [Expert Panel Member] of the Deutsche Forschungsgemeinschaft
2016 – 2019 Fachkollegiat [Expert Panel Member] of the Deutsche Forschungsgemeinschaft (Rheumatologie, Klinische Immunologie)
2014 – 2018 Member of the EULAR Standing Committee on Investigative Rheumatology
2013 – 2022 Member of the Board of the German Society of Rheumatology
2013 – 2016 Speaker of the Kompetenznetzwerk Rheumatologie of the German Society of Rheumatology
2012 – 2015 Fachkollegiat [Expert Panel Member] of the Deutsche Forschungsgemeinschaft (Rheumatologie, Klinische Immunologie)
2011 President of the 39th Annual Meeting of the German Society of Rheumatology
2009 – 2012 Member of the Advisory Board of the German Society of Rheumatology
2008 – Member of the expert advisory board and rheumatology examiner of the Bavarian Medical Association
2006 Wolfgang Schulze Foundation Award (German League against Rheumatism)
2005 Offer to full professorship Internal Medicine/Rheumatology at the Ludwig-Maximilians-University Munich (W2)
2003 Certification as Immunologist, German Society for Immunology
2002 2nd Term, Head, Clinical Research Group III: “T cells in the pathogenesis of human autoimmune diseases”, Nikolaus Fiebiger Center for Molecular Medicine, Friedrich Alexander University Erlangen-Nuremberg
2001 European League Against Rheumatism Young Investigator Award
2001 Japanese Rheumatism Organization Young Investigator Award
2000 Lecturer in Clinical Immunology (Habilitation)
1999 – Member of the Editorial Board of the Annals of the Rheumatic Diseases
1999 Young Investigator Award, Dr. Walter and Luise Freundlich Foundation, Frankfurt/Main, for basic science in rheumatology
1999 Head, Clinical Research Group III: “T cells in the pathogenesis of human autoimmune diseases”, Nikolaus Fiebiger Center for Molecular Medicine, Friedrich Alexander University Erlangen-Nuremberg
1998 European League Against Rheumatism Junior Rheumatologist Award
1996 American College of Rheumatology Research & Education Foundation Award
1994 Postdoctoral Fellowship, Deutscher Akademischer Austauschdienst
1993 Postdoctoral Fellowship, Deutscher Akademischer Austauschdienst
1992 Postdoctoral Fellowship, Deutsche Forschungsgemeinschaft
1990 Dissertation, “magna cum laude”
Richard Taubert, Germany
Richard Taubert
He is a Senior Physician and Research Group Leader in the Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology at Hanover Medical School in Hanover, Germany.
He studied medicine at the University of Heidelberg and Baylor College of Medicine in Houston, Texas (2000–2007). He completed his MD thesis in the field of basic immunology at the German Cancer Research Centre in Heidelberg in 2003–2004.
He completed his residency and fellowships in internal medicine, gastroenterology and transplantation medicine at Hannover Medical School in 2017, 2020 and 2024 respectively. He was a research postdoc for more than four years and has been a research PI and group leader on immune-mediated liver diseases before and after liver transplantation at Hannover Medical School since 2013. He has been a consultant in gastroenterology since 2019. He was awarded his Habilitation in Internal Medicine in 2019, and has been an Extraordinary Professor at Hannover Medical School since 2024.
Huji Xu, China
Christoph Ellebrecht
Shuang Ye, China
